Integrating specialty pharmacy staff into oncology, neurology, rheumatology, and other specialty clinics within their health systems is a growing trend with a range of beneficial outcomes.
These actions can eliminate vulnerabilities and ensure greater supply chain resiliency for the next pandemic—and beyond.
Pharmacists who immunize must ensure their knowledge about routine vaccinations for adults and children is up-to-date by reviewing the changes to the immunization schedule each year.
A retrospective evaluation to assess whether medications for patients undergoing bariatric procedures are effectively optimized to ensure safe medication transitioning.
Specialty pharmacies serve as a hub of services for all stakeholders, offering comprehensive support programs for patients and data-driven clinical intelligence for providers and payers.
Since the introduction of biologics to treat rheumatoid arthritis, there has been a reduction in total hip and total knee replacement surgeries among rheumatoid arthritis patients.
Most notably, COVID-19 has transformed the landscape for medical science liaisons (MSLs) by forcing them to rapidly adapt to the present circumstances.
An overview of the utilization and cost for selected oral antineoplastic agents, with discussion regarding oncology in general, as well as the topic of adherence.
Medication therapy management has become an important buzzword in the world of pharmacy.
Vaccination with trivalent live attenuated versus inactivated influenza vaccine in children aged 2 to 17 years is cost saving or cost-effective depending on the severity of the influenza season.
The use of health information technology empowers pharmacists to provide enhanced care by harnessing a wealth of actionable information.
The transition in specialty pharmacy from traditional prescription ordering processes to e-prescribing brings challenges and benefits.
The rate of palliative care in patients with multiple sclerosis to have died in US hospitals increased from 7.7% to 58.8% over 10 years
Many new antiviral drugs that treat hepatitis C have similar efficacy, but come with different advantages and disadvantages.
Incentive formularies with varying cost sharing led to modestly lower overall spending, with savings for plan sponsors offset by increased out-of-pocket spending.
Warnings about the risk of ketoacidosis and serious urinary tract infections have been added to the labels of SGLT2 inhibitors.
Since the introduction of biologics to treat rheumatoid arthritis, there has been a reduction in total hip and total knee replacement surgeries among rheumatoid arthritis patients.
It is understood that a person’s genetics determines traits such as eye, hair, and skin color and even the predisposition to contracting certain diseases.
This study applied a validated algorithm to estimate the effectiveness and costs of the index biologic used by 4696 US veterans with rheumatoid arthritis.
To better accommodate this significant portion of the population, a new form of health care has broken through to redefine the nature of medici- nal services: telehealth.